Pre-Clinical Research: Why and When to Invest — 2023 RARE Advocacy Summit

January 19, 2024

As part of the Becoming a Research Ready Organization track from the 2023 RARE Advocacy Summit, this session will explore essential tools for basic research including animal models, induced pluripotent stem cells, and next generation sequencing.

Pre-Clinical Research: Why and When to Invest

Yael Weiss, MD, PhD
CEO, Mahzi Therapeutics

* Gene Yeo, PhD, MBA
Professor of Cellular and Molecular Medicine, University of California, San Diego

* Jeffrey Kaufman
Executive Director, Adenoid Cystic Carcinoma Research Foundation
Co-Founder, Treasurer, Director of Research, Ring 14 USA

Stay Connected

Sign up for updates straight to your inbox.